A new data-driven study tracked and analyzed gout-related healthcare costs for more than three years, determining the financial burden of flares and the possible benefit of proper flare management…
Search results for: Gout
Phase 3 Studies Evaluate Lesinurad for Gout Treatment
For 12 months, two studies examined the use of lesinurad in combination with allopurinol to treat gout, with patients achieving reduced serum uric acid levels and demonstrating no severe toxicity.
Generic Colchicine Approved for Gout Prophylaxis
The cost for therapeautic gout treatment may soon go down, thanks to a recent court ruling
2014 ACR/ARHP Annual Meeting: New Directions for Gout
Economics of care, more aggressive treatment targets needed for better gout management
Metabolic Biosensor Implicated in Gout
AMP-activated protein kinase may be link between nutritional excess, inflammation that leads to gout
Gout, Glucose Metabolism and Obesity: A Case Review
New research explores association between hyperurecimia and gout with metabolic derangement
Treatment, Management Options for Difficult-to-Control Gout
Patient education is key to medication compliance, battling gouty flares
Rheumatologists’ Involvement Aids in Gout Diagnosis, Follow-up for Inpatients
Two studies find rheumatologists can help optimally manage gout episodes
Bariatric Surgery May Help Obese Patients with Gout, Diabetes
Researchers found patients with morbid obesity, gout and diabetes achieved target serum urate concentrations post-bariatric surgery
Treatment Options, Guidelines for Managing Gout Discussed at the ACR/ARHP Winter Rheumatology Symposium
Better understanding of goals, effect of gout therapy with nonsteroidal anti-inflammatory drugs, urate lowering medication needed to improve quality of care
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 59
- Next Page »